PROXY STATEMENT

Company

ADIAL PHARMACEUTICALS, INC.

Filed

March 6, 2023

Period of Report

April 12, 2023

Accession Number

0001213900-23-017857

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →